Adma Biologics | ADMA - Operating Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Adma Biologics

Adma Biologics reported $17.33M in Operating Expenses for its fiscal quarter ending in March of 2023.


Operating Expenses Change
Adamis Pharmaceuticals ADMP:US USD 7.88M 1.9M
Adma Biologics ADMA:US USD 17.33M 38.71M
Alnylam Pharmaceuticals ALNY:US USD 469.1M 54.55M
BioCryst Pharmaceuticals BCRX:US USD 97.19M 28.66M
Dynavax Technologies DVAX:US USD 77.17M 44.18M
Minerva Neurosciences NERV:US USD 5.35M 278.79K
Novavax NVAX:US USD 393.72M 207.56M
Takeda 4502:JP JPY 867.59B 81.97B